18.27
Sanuwave Health Inc stock is traded at $18.27, with a volume of 45,205.
It is up +4.34% in the last 24 hours and down -15.08% over the past month.
SANUWAVE Health Inc is a medical device company providing directed energy products into the wound care space. It is focused on the commercialization of its patented regenerative medicine utilizing noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. Sanuwave's patented, FDA-cleared, and commercialised product is the UltraMIST system, which is used to treat a variety of acute and chronic wounds using ultrasound technology. The company operates in one reportable segment, the design and sale of medical devices. Geographically, the company generates revenue mainly from the United States.
See More
Previous Close:
$17.51
Open:
$17.67
24h Volume:
45,205
Relative Volume:
0.68
Market Cap:
$157.02M
Revenue:
$44.05M
Net Income/Loss:
$11.81M
P/E Ratio:
-107.72
EPS:
-0.1696
Net Cash Flow:
$1.93M
1W Performance:
+3.81%
1M Performance:
-15.08%
6M Performance:
-45.14%
1Y Performance:
-37.65%
Sanuwave Health Inc Stock (SNWV) Company Profile
Name
Sanuwave Health Inc
Sector
Industry
Phone
952-656-1029
Address
9600 W. 6TH SSTREET, EDEN PRAIRIE
Compare SNWV vs MOBBW, GOODO, PSNYW, SHMD, DWLD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
SNWV
Sanuwave Health Inc
|
29.00 | 34.02M | 0 | 0 | 0 | 0.00 |
|
MOBBW
Mobilicom Limited Warrants
|
1.82 | 2.55B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
19.85 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
3.70 | 356.14M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
SHMD
Schmid Group N V
|
5.81 | 315.27M | 52.15M | -21.46M | 0 | -0.4675 |
|
DWLD
Davis Select Worldwide ETF
|
46.21 | 0 | 0 | 0 | 0 | 0.00 |
Sanuwave Health Inc Stock (SNWV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-03-25 | Initiated | Northland Capital | Outperform |
| Jul-29-25 | Initiated | Roth Capital | Buy |
Sanuwave Health Inc Stock (SNWV) Latest News
Aug Opening: Can SANUWAVE Health Inc deliver consistent dividends2026 Outlook & Reliable Trade Execution Plans - baoquankhu1.vn
Aug Big Picture: How liquid is SANUWAVE Health Inc stockWeekly Stock Summary & AI Driven Price Predictions - baoquankhu1.vn
How The SANUWAVE Health (SNWV) Investment Narrative Is Resetting After A Lower Price Target - Yahoo Finance
SANUWAVE Health Inc (SNWV) Shares Fall 7.2% -- GF Value Says Still Overvalued - GuruFocus
Aug Mood: Is SANUWAVE Health Inc likely to announce a buybackJobs Report & Consistent Profit Trade Alerts - baoquankhu1.vn
Travel Stocks: Why is SANUWAVE Health Inc stock going downTrade Exit Report & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
Sanuwave Health Q4 2025 Earnings Call Transcript - MarketBeat
Update Recap: Is SANUWAVE Health Inc being accumulated by smart moneyQuarterly Portfolio Report & Risk Adjusted Swing Trade Ideas - baoquankhu1.vn
Head to Head Survey: Sanuwave Health (NASDAQ:SNWV) and INLIF (NASDAQ:INLF) - Defense World
SANUWAVE Health Inc (SNWV) Stock Price Up 1.48% on Apr 6 - GuruFocus
Setup Watch: Is SANUWAVE Health Inc stock undervalued right now2026 Sector Moves & AI Based Trade Execution Alerts - baoquankhu1.vn
Macro Review: Can SANUWAVE Health Inc generate free cash flow2026 Movers & Weekly High Return Forecasts - baoquankhu1.vn
Sanuwave Health Posts Record Results Amid CMS Shock - TipRanks
SNWV SEC FilingsSanuwave Health 10-K, 10-Q, 8-K Forms - Stock Titan
Director Tyler James granted 3,208 SANUWAVE (SNWV) stock options at $17.29 - Stock Titan
SANUWAVE Health (SNVW) CEO Frank Morgan awarded 3,208 stock options - Stock Titan
[Form 4] SANUWAVE Health, Inc. Insider Trading Activity - Stock Titan
Director at SANUWAVE Health (SNVW) gets 3,208 fully vested options - Stock Titan
Sanuwave Health (NASDAQ:SNWV) Rating Lowered to "Strong Sell" at Zacks Research - MarketBeat
Sanuwave Health (NASDAQ:SNWV) Given “Buy” Rating at Roth Mkm - Defense World
Sanuwave Health (SNWV) Projected to Post Earnings on Tuesday - MarketBeat
SNWV Sees Updated Analyst Rating: Roth Capital Lowers Price Targ - GuruFocus
Roth Mkm Reiterates "Buy" Rating for Sanuwave Health (NASDAQ:SNWV) - MarketBeat
SANUWAVE outlines 16–25% revenue growth target for 2026 as reseller expansion accelerates - MSN
Aug Levels: What drives SANUWAVE Health Incs stock priceWeekly Stock Recap & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
How The Reset Price Target Is Rewriting The Story For SANUWAVE Health (SNWV) - Yahoo Finance
Sanuwave Health Q4 Earnings Call Highlights - Defense World
SANUWAVE Health, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
SANUWAVE Q4 2025 slides: record revenue, stock tumbles on concerns By Investing.com - Investing.com Australia
Sanuwave Health (NASDAQ:SNWV) Downgraded by Wall Street Zen to Hold - MarketBeat
SANUWAVE Health Hits 52-Week Low at $18.61 Amid Market Volatility - Markets Mojo
Vanguard disaggregates holdings in SANUWAVE (NASDAQ: SNWV) — 0% reported - Stock Titan
Sanuwave Announces Record Revenues and Financial Results for Q4 and Full Year 2025 - Ortho Spine News
Death Cross: Why is SANUWAVE Health Inc stock going down2026 Stock Rankings & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Earnings call transcript: SANUWAVE’s Q4 2025 revenue hits record, stock dips premarket - Investing.com Australia
SANUWAVE Q4 2025 slides: record revenue, stock tumbles on concerns - Investing.com India
Earnings call transcript: SANUWAVE’s Q4 2025 revenue hits record, stock dips premarket By Investing.com - Investing.com South Africa
SNWV: Record revenue and EBITDA growth achieved amid industry disruption and strategic channel expansion - TradingView
SANUWAVE Health Inc reports results for the quarter ended December 31Earnings Summary - TradingView — Track All Markets
SANUWAVE Health, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:SNWV) 2026-03-27 - Seeking Alpha
Q4 2025 SANUWAVE Health Inc Earnings Call Transcript - gurufocus.com
Sanuwave Q4 2025 revenue up 29.7% to USD 13.4M - Medical Buyer
Sanuwave Health Reports Record 2025 Revenues with 35% Growth and Strong Outlook for 2026 - Minichart
SNWV: Q4 2025 delivered 30% revenue growth and record UltraMIST sales, with strong FY 2026 outlook - TradingView
Sanuwave Health (NASDAQ:SNWV) Issues Earnings Results, Misses Estimates By $0.14 EPS - MarketBeat
SANUWAVE Health posts record Q4 revenue $13.4M, full-year 2025 revenue $44.1M - TradingView
SNWV: Record 2025 revenue and profit, with strong UltraMist sales and robust 2026 growth outlook - TradingView
[8-K] SANUWAVE Health, Inc. Reports Material Event - Stock Titan
Sanuwave sold 255 wound-care systems in Q4, targets up to $55M - Stock Titan
Sanuwave Health, Inc. Provides Revenue Guidance for the First Quarter and Full Year 2026 - marketscreener.com
Sanuwave (SNWV) posts 35% revenue growth but restates prior results - Stock Titan
Sanuwave Health Inc Stock (SNWV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Sanuwave Health Inc Stock (SNWV) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| MANCHESTER MANAGEMENT CO LLC | Director by Deputization |
Dec 12 '25 |
Sale |
21.04 |
6,500 |
136,789 |
63,999 |
| MANCHESTER MANAGEMENT CO LLC | Director by Deputization |
Dec 08 '25 |
Sale |
30.75 |
125,400 |
3,856,050 |
881,390 |
| MANCHESTER MANAGEMENT CO LLC | Director by Deputization |
Dec 09 '25 |
Sale |
30.58 |
8,785 |
268,679 |
872,605 |
| MANCHESTER MANAGEMENT CO LLC | Director by Deputization |
Dec 10 '25 |
Sale |
30.39 |
8,625 |
262,129 |
863,980 |
| MANCHESTER MANAGEMENT CO LLC | Director by Deputization |
Dec 08 '25 |
Sale |
31.60 |
2,000 |
63,203 |
2,000 |
| Opaleye Management Inc. | 10% Owner |
Oct 06 '25 |
Buy |
30.28 |
1,267 |
38,361 |
966,267 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):